The consumer’s underlying theory that “heart healthy” packaging statements and the use of a heart symbol make buyers falsely believe the supplement has an effect on cardiovascular disease was preempted by federal regulations, the US District Court for the Northern District of California said Oct. 18.
Judge William H. Orrick noted the question at the heart of the case was whether the label statements were function claims, which are preempted ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.